Clearpoint Neuro (CLPT) revenue breakdown
By product, Neurosurgery Navigation and Therapy - Disposable Products is the largest at 40% of fiscal 2025 revenue; Biologics and Drug Delivery - Services and License Fees grew fastest, 29% a year over 3 years.
Revenue by product
Fiscal years, as Clearpoint Neuro reports them in its 10-K filings; fiscal 2025 total $37M.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurosurgery Navigation and Therapy - Disposable Products | — | — | — | — | — | $8M | $8M | $10M | $15M | 40% |
| Biologics and Drug Delivery - Services and License Fees | — | — | — | — | — | $5M | $11M | $12M | $12M | 32% |
| Biologics and Drug Delivery - Disposable Products | — | — | — | — | — | $4M | $2M | $6M | $7M | 20% |
| Capital Equipment and Software - Systems and Software Products | — | — | — | — | — | $2M | $860,000 | $3M | $2M | 5% |
| Capital Equipment and Software - Services | — | — | — | — | — | $795,000 | $973,000 | $1M | $1M | 4% |
| Product revenue | $7M | $7M | $10M | $9M | $12M | — | — | — | — | — |
| Service and other revenue | $355,515 | $668,246 | $1M | $4M | $4M | — | — | — | — | — |
| Neurosurgery Navigation and Therapy - Services | — | — | — | — | — | $2M | $931,000 | — | — | — |
Questions
Where does Clearpoint Neuro make its money?
In fiscal 2025, by product: Neurosurgery Navigation and Therapy - Disposable Products $15M, Biologics and Drug Delivery - Services and License Fees $12M, Biologics and Drug Delivery - Disposable Products $7M, Capital Equipment and Software - Systems and Software Products $2M, Capital Equipment and Software - Services $1M.
From Clearpoint Neuro's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.